Process for preparing modulators of cystic fibrosis transmembrane conductance regulator

Details for Australian Patent Application No. 2010310612 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Ambhaikar, Narendra Bhalchandra; Hughes, Robert; Hurley, Dennis James; Lee, Elaine Chungmin; Littler, Benjamin; Numa, Mehdi; Roeper, Stefanie; Sheth, Urvi

Agent Cullens

Pub. Number AU-A-2010310612

PCT Pub. Number WO2011/050215

Priority 61/254,634 23.10.09 US

Filing date 21 October 2010

Wipo publication date 28 April 2011

International Classifications

C07D 215/56 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 487/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

14 June 2012 PCT application entered the National Phase

  PCT publication WO2011/050215 Priority application(s): WO2011/050215

16 August 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 23 May 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010310617-Solid forms of N- (4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-trif luoromethyl)phenyl)-4-oxo-5-(trifluoromethyl) -1,4-dihydroquinoline-3-carboxamide

2010310605-Bariatric device and method for weight loss